Clinical trial
Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis
NCT04495556 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis
- Lead sponsor
- The Cleveland Clinic
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 11, 2020
- Completion date
- January 31, 2027
- Enrollment
- 420 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.